Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: Two possible perlecan signalling pathways for cellular growth and differentiation

Histopathology

Volumn 58, Issue 2, 2011, Pages 234-245

  Ida Yonemochi, Hiroko ^a   Ahsan, Md Shahidul ^a   Saku, Takashi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

dystroglycan; Ameloblastoma; Integrin 1; Intraepithelial stroma; Perlecan

Indexed keywords

ALPHA DYSTROGLYCAN; BETA1 INTEGRIN; PERLECAN;

AMELOBLASTOMA; ARTICLE; BASEMENT MEMBRANE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR LOCALIZATION;

AMELOBLASTOMA; ANTIGENS, CD29; CELL DIFFERENTIATION; CELL PROLIFERATION; DYSTROGLYCANS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; JAW NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 79951677676     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03732.x     Document Type: Article

References (34)

1. Ida-Yonemochi H, Ohshiro K, Swelam W et al. Perlecan, a basement membrane-type heparan sulfate proteoglycan, in the enamel organ: its intraepithelial localization in the stellate reticulum. J. Histochem. Cytochem. 2005; 53; 763-772.
2. Ida-Yonemochi H, Ikarashi T, Nagata M et al. The basement membrane-type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture. Virchows Arch. 2002; 441; 165-173.
3. Ikarashi T, Ida-Yonemochi H, Ohshiro K et al. Intraepithelial expression of perlecan, a basement membrane type heparan sulfate proteoglycan, reflects in dysplastic changes of the oral mucosal epithelium. J. Oral Pathol. Med. 2004; 33; 71-78.
4. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. Histological typing of cancer and precancerous of the oral mucosa, World Health Organization international histological classification of tumors. Berlin: Springer-Verlag, 1997; 25-26.
5. Ida-Yonemochi H, Saku T. Perlecan, a heparan sulfate proteoglycan, is a major constituent of the intraepithelial stroma functioning in tooth morphogenesis. J. Oral Biosci. 2006; 48; 233-243.
6. Henry MD, Satz JS, Brakebusch C et al. Distinct roles for dystroglycan, β1 integrin and perlecan in cell surface laminin organization. J. Cell Sci. 2001; 114; 1137-1144.
7. Peng H, Shah W, Holland P, Carbonetto S. Integrins and dystroglycan regulate astrocyte wound healing: the integrin beta1 subunit is necessary for process extension and orienting the microtubular network. Dev. Neurobiol. 2008; 68; 559-574.
8. Talts JF, Andac Z, Göhring W et al. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J. 1999; 18; 863-870.
9. Esapa CT, Bentham GR, Schroder JE et al. The effects of post-translational processing on dystroglycan synthesis and trafficking. FEBS Lett. 2003; 555; 209-216.
10. Winder SJ. The complexities of dystroglycan. Trends Biochem. Sci. 2001; 26; 118-124.
11. Andac Z, Sasaki T, Mann K et al. Analysis of heparin, alpha-dystroglycan and sulfatide binding to the G domain of the laminin alpha 1 chain by site-directed mutagenesis. J. Mol. Biol. 1999; 287; 253-264.
12. Anderson C, Winder SJ, Borycki AG. Dystroglycan protein distribution coincides with basement membranes and muscle differentiation during mouse embryogenesis. Dev. Dyn. 2007; 236; 2627-2635.
13. Durbeej M, Larsson E, Ibraghimov-Beskrovnaya O et al. Non-muscle alpha-dystroglycan is involved in epithelial development. J. Cell Biol. 1995; 130; 79-91.
14. Durbeej M, Talts JF, Henry MD et al. Dystroglycan binding to laminin α1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro. Differentiation 2001; 69; 121-134.
15. Whitelock JM, Melrose J, Iozzo RV. Diverse cell signaling events modulated by perlecan. Biochemistry 2008; 47; 11174-11183.
16. Katz BZ, Yamada KM. Integrins in morphogenesis and signaling. Biochimie 1997; 79; 467-476.
17. Varner JA, Cheresh DA. Integrins and cancer. Curr. Opin. Cell Biol. 1996; 8; 724-730.
18. Andrade ESS, Miguel CC, Pinto LP, Souza LB. Ameloblastoma and adenomatoid odontogenic tumor: the role of α2β1, α3β1, and α5β1 integrins in local invasiveness and architectural characteristics. Ann. Diagn. Pathol. 2007; 11; 199-205.
19. Modolo F, Martins MT, Loducca SVL, Araújo VC. Expression of integrin subunits α2, α3, α5, αv, β1, β3 and β4 in different histological types of ameloblastoma compared with dental germ, dental lamina and adult lining epithelium. Oral Dis. 2004; 10; 277-282.
20. Saku T, Furthmayr H. Characterization of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture: homology to the large molecular weight molecule of basement membranes. J. Biol. Chem. 1989; 264; 3514-3523.
21. Cheng J, Irié T, Munakata R et al. Biosynthesis of basement membrane molecules by salivary adenoid cystic carcinoma cells: an immunofluorescence and confocal microscopic study. Virchows Arch. 1995; 426; 577-586.
22. Kobayashi Y, Nakajima T, Saku T. Loss of basement membranes in the invading front of O-1N, hamster squamous cell carcinoma with high potential of lymph node metastasis: an immunohistochemical study for laminin and type IV collagen. Pathol. Int. 1995; 45; 327-334.
23. Costell M, Gustafsson E, Aszodi A et al. Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 1999; 147; 1109-1122.
24. Handler M, Yurchenco PD, Iozzo RV. Developmental expression of perlecan during murine embryogenesis. Dev. Dyn. 1997; 210; 130-145.
25. Iozzo RV, Cohen IR, Grassel S, Murdoch AD. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 1994; 302; 625-639.
26. Jiang X, Multhaupt H, Chan E et al. Essential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesis. J. Histochem. Cytochem. 2004; 52; 1575-1590.
27. Kimura S, Cheng J, Ida H et al. Perlecan (heparan sulfate proteoglycan) gene expression reflect in the characteristic histological architecture of salivary adenoid cystic carcinoma. Virchows Arch. 2000; 437; 122-128.
28. Adatia R, Albini A, Carlone S et al. Suppression of invasive behavior of melanoma cells by stable expression of antisense perlecan cDNA. Ann. Oncol. 1997; 8; 1257-1261.
29. Sharma B, Handler M, Eichstetter I et al. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J. Clin. Invest. 1998; 102; 1599-1608.
30. Henry MD, Campbell KP. A role for dystroglycan in basement membrane assembly. Cell 1998; 95; 859-870.
31. Henry MD, Campbell KP. Dystroglycan inside and out. Curr. Opin. Cell Biol. 1999; 11; 602-607.
32. Sgambato A, Salvatore MA, Paola DE et al. Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis. J. Cell. Physiol. 2006; 207; 520-529.
33. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001; 411; 375-379.
34. Miller SE, Veale RB. Environmental modulation of αv, α2 and β1 integrin subunit expression in human esophageal squamous cell carcinomas. Cell Biol. Int. 2001; 25; 61-69.